Correlation Between Creo Medical and Concurrent Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Creo Medical and Concurrent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Creo Medical and Concurrent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Creo Medical Group and Concurrent Technologies Plc, you can compare the effects of market volatilities on Creo Medical and Concurrent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Creo Medical with a short position of Concurrent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Creo Medical and Concurrent Technologies.

Diversification Opportunities for Creo Medical and Concurrent Technologies

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Creo and Concurrent is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Creo Medical Group and Concurrent Technologies Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Concurrent Technologies and Creo Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Creo Medical Group are associated (or correlated) with Concurrent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Concurrent Technologies has no effect on the direction of Creo Medical i.e., Creo Medical and Concurrent Technologies go up and down completely randomly.

Pair Corralation between Creo Medical and Concurrent Technologies

Assuming the 90 days trading horizon Creo Medical is expected to generate 19.55 times less return on investment than Concurrent Technologies. In addition to that, Creo Medical is 1.02 times more volatile than Concurrent Technologies Plc. It trades about 0.03 of its total potential returns per unit of risk. Concurrent Technologies Plc is currently generating about 0.55 per unit of volatility. If you would invest  13,200  in Concurrent Technologies Plc on October 30, 2024 and sell it today you would earn a total of  5,000  from holding Concurrent Technologies Plc or generate 37.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Creo Medical Group  vs.  Concurrent Technologies Plc

 Performance 
       Timeline  
Creo Medical Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Creo Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Creo Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Concurrent Technologies 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Concurrent Technologies Plc are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Concurrent Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Creo Medical and Concurrent Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Creo Medical and Concurrent Technologies

The main advantage of trading using opposite Creo Medical and Concurrent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Creo Medical position performs unexpectedly, Concurrent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concurrent Technologies will offset losses from the drop in Concurrent Technologies' long position.
The idea behind Creo Medical Group and Concurrent Technologies Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences